Treatment of SSRI-Resistant Depression In Adolescents (TORDIA)

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

334

Participants

Timeline

Start Date

January 31, 2001

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions
Depression
Interventions
DRUG

Fluoxetine

Standard anti-depressant treatment with the SSRI fluoxetine

DRUG

Venlafaxine

Standard antidepressant treatment with the non-SSRI medication venlafaxine

BEHAVIORAL

Cognitive Behavioral Therapy (CBT)

CBT addresses maladaptive beliefs in order to encourage behavioral change

DRUG

Citalopram

Standard anti-depressant treatment with the SSRI fluoxetine

Trial Locations (6)

15213

Western Psychiatric Institute and Clinic of University of Pittsburgh Medical Center, Pittsburgh

90095-6967

University of California at Los Angeles, Los Angeles

97227-1098

Kaiser Permanente Center for Health Research, Portland

02906

Brown University, Providence

75390-8589

University of Texas - Southwestern Medical Center, Dallas

77555-0188

University of Texas Medical Branch, Galveston

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of Pittsburgh

OTHER

NCT00018902 - Treatment of SSRI-Resistant Depression In Adolescents (TORDIA) | Biotech Hunter | Biotech Hunter